S&P 500 7,591.70 −0.58%
Nasdaq 26,081.73 −0.65%
S&P/TSX 35,506.28 −1.11%
Apple 326.57 +3.56%
Nvidia 218.36 −2.37%
Microsoft 492.44 +0.16%
Shopify 175.14 +0.01%
Royal Bank 284.98 −0.21%
CAD/USD 0.7225 −0.26%
CLOSED · 01:00 ET
Market ClerkRecap
Fri Sep 11 · markets closed4 signals on Sep 10223 insider buys this week · $359.5MCIRO short report next: Sep 14The week ahead

GRCE

Grace Therapeutics, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
2.26
+0.12 +5.61%
USD · close Sep 10

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Insider trading

SEC FORM 4 · OPEN-MARKET ONLY
+$246K
Net, 90 days
3 / 0
Buys / sells, 90 days
2
Distinct buyers
$246K
Bought, 90 days
TradedFiledInsiderTypeSharesPriceValue
Sep 9Sep 10Opaleye Management Inc. · 10% ownerBuy5,836$2.09$12K
Sep 9Sep 10Kohli Prashant · Chief Executive OfficerBuy100,000$2.14$214K
Sep 8Sep 10Opaleye Management Inc. · 10% ownerBuy9,393$2.10$20K

Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.

Watch GRCE. Know when insiders buy.
One email the day a filing lands. Free.